Related Experiment Video
Updated: Jul 13, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Kimura disease: diagnosis and prognostic factors
Hiroshi Iwai1, Kaoru Nakae, Koshi Ikeda
1Department of Otolaryngology, Kansai Medical University, Osaka, Japan. iwai@takii.kmu.ac.jp
Summary
Kimura disease can be diagnosed preoperatively in Asian patients using MRI and eosinophil counts. High eosinophil counts, IgE levels, and multifocal lesions predict recurrence, guiding treatment for better outcomes.
Area of Science:
- Rare diseases
- Oncology
- Immunology
Background:
- Kimura disease is a rare inflammatory condition.
- Definitive treatment policies remain undetermined.
- Accurate preoperative diagnosis and prognostic evaluation are crucial.
Purpose of the Study:
- To establish a preoperative diagnostic system for Kimura disease.
- To identify prognostic factors for disease recurrence.
Main Methods:
- Retrospective study of nine Kimura disease cases.
- Review of hospital records.
- Examination of preoperative eosinophil counts in 74 parotid gland malignancy cases.
Main Results:
- MRI findings (parotid swelling, subcutaneous invasion) and eosinophil counts > 10.5% in Asian patients indicate Kimura disease.
- Eosinophils > 50%, IgE > 10,000 IU/mL, and multifocal lesions predict recurrence.
Conclusions:
- A preoperative diagnostic system based on MRI and eosinophil counts can aid in identifying Kimura disease.
- Identified prognostic factors can guide therapeutic strategies.
- Improved diagnostic and prognostic understanding may lead to better therapeutic outcomes.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...